Flagship Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.41M Buy
9,415
+225
+2% +$77K 2.15% 15
2026
Q1
$3.23M Buy
9,190
+533
+6% +$190K 2.38% 14
2025
Q4
$2.83M Buy
+8,657
New +$2.75M 2% 16

Other funds holding AMGN

Flagship Capital Management's AMGN Position: Q2 2026 in Review

Flagship Capital Management increased its Amgen (AMGN) stake by 2.4% in Q2 2026, buying an estimated $77K and bringing the position to 9,415 shares worth $3.41M. The position accounts for 2.15% of the portfolio, ranked #15.

Flagship Capital Management first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 2,102 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Flagship Capital Management held 9,415 shares of Amgen worth $3.41M as of Q2 2026.
  • Flagship Capital Management bought 225 Amgen shares in Q2 2026, an estimated $77K.
  • Amgen made up 2.15% of Flagship Capital Management's portfolio in Q2 2026, its #15 holding.
  • Flagship Capital Management first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 2,102 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Flagship Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.